About
Technology
Issues
FAQ
Links
Official Page
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.